BIO-key International, Inc. (NASDAQ:BKYI – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.50 and traded as low as $0.63. BIO-key International shares last traded at $0.68, with a volume of 204,401 shares trading hands.
BIO-key International Price Performance
The business has a 50-day moving average of $1.14 and a 200 day moving average of $1.49. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.54 and a quick ratio of 0.46.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The technology company reported ($1.00) EPS for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.46). The company had revenue of $1.14 million for the quarter. BIO-key International had a negative return on equity of 673.82% and a negative net margin of 93.18%.
BIO-key International Company Profile
BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.
Featured Articles
- Five stocks we like better than BIO-key International
- What Are Dividend Challengers?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.